Europe Anticoagulant Reversal Drug Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Prothrombin Complex Concentrates, Vitamin K, Protamine, Tranexamic Acid, Idarucizumab, and AndeXXa); End User (Hospital Pharmacies, Retail Pharmacies, and Others)

TIPRE00022194 | Pages: 146 | Pharmaceuticals | May 2021 | Type: Regional | Status: Published

Market Introduction

Anticoagulant reversal drugs are required to reverse the effect of anticoagulation in certain situations such as unplanned surgery, overdose of anticoagulant therapy, and uncontrolled bleeding. In medical conditions such as venous thromboembolism, atrial fibrillation (AF), mechanical valve replacement, and other coagulation disorders such as antiphospholipid antibody syndrome, Factor V Leiden, anticoagulant reversal drugs are used.

Thus, the increasing prevalence of stroke is expected to create a significant demand for anticoagulant reversal drugs in the coming years, which is further anticipated to drive the anticoagulant reversal drug market.

 


Get more information on this report :



Market Overview and Dynamics

The anticoagulant reversal drug market in Europe is expected to grow from US$ 270.0 million in 2019 to US$ 655.4 million by 2027; it is estimated to grow at a CAGR of 12.4% from 2019 to 2027. Rapidly progressing research activities in drug development of novel therapeutics across the world to counter the growing prevalence of cardiovascular diseases, such as atrial fibrillation is driving the growth of the anticoagulant reversal drugs market. There is always a need for innovative therapeutic approaches in the treatment of various cardiovascular indications. For instance, the study titled ‘Evaluation of andexanet alfa and fourfactor prothrombin complex concentrate (4FPCC) for reversal of rivaroxaban and apixabanassociated intracranial hemorrhages,’ published in February 2020, to investigate the efficacy of andexanet alfa in the treatment of intracranial hemorrhages (ICH). This is bolstering the growth of the anticoagulant reversal drug market.

 

Key Market Segments

In terms of product, the prothrombin complex concentrates segment accounted for the largest share of the Europe anticoagulant reversal drug market in 2019. In terms of distribution channel, the hospital pharmacies segment held a larger market share of the anticoagulant reversal drug market in 2019.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the anticoagulant reversal drug market in Europe are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Boehringer Ingelheim International GmbH, Pfizer Inc, Octapharma AG, AMAG PHARMACEUTICALS, INC., Fresenius Kabi AG, Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals), CSL Limited, and Grifols, S.A.

Reasons to buy report

  • To understand the Europe anticoagulant reversal drug market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for Europe anticoagulant reversal drug market
  • Efficiently plan M&A and partnership deals in Europe anticoagulant reversal drug market by identifying market segments with the most promising probable sales
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Europe anticoagulant reversal drug market
  • Obtain market revenue forecast for market by various segments from 2021-2028 in Europe region.

EUROPE ANTICOAGULANT REVERSAL DRUG MARKET SEGMENTATION

By Product

  • Prothrombin Complex Concentrates
  • Vitamin K
  • Protamine
  • Tranexamic Acid
  • Idarucizumab
  • AndeXXa

 

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

 

By Country

  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe

 

 

Companies Mentioned

  • Boehringer Ingelheim International GmbH
  • Pfizer Inc
  • Octapharma AG
  • AMAG PHARMACEUTICALS, INC.
  • Fresenius Kabi AG
  • Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)
  • CSL Limited
  • Grifols, S.A.      

 

 

TABLE OF CONTENTS

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Anticoagulant Reversal Drug Market – By Product

1.3.2        Anticoagulant Reversal Drug Market – By Distribution Channel

1.3.3        Europe Anticoagulant Reversal Drug Market – By Country

2.           Europe Anticoagulant Reversal Drug Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Anticoagulant Reversal Drug Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Anticoagulant Reversal Drug Market- Europe PEST Analysis

4.3         Expert Opinion

5.           Europe Anticoagulant Reversal Drug Market - Key Market Dynamics

5.1         Market Drivers

5.1.1        Rise in Prevalence of Atrial Fibrillation (AFib)

5.1.2        Increase in Prevalence of Stroke

5.2         Market Restraints

5.2.1        High Cost of Anticoagulant Reversal Drugs

5.3         Market Opportunities

5.3.1        Increasing Research Activities on Anticoagulant Reversal Drugs

5.4         Future Trends

5.4.1        Development and Launch of Innovative Products

5.5         Impact Analysis

6.           Anticoagulant Reversal Drug Market – Europe Analysis

6.1         Europe Anticoagulant Reversal Drug Market Revenue Forecasts and Analysis

7.           Europe Anticoagulant Reversal Drug Market Analysis and Forecasts To 2027 – By Product

7.1         Overview

7.2         Anticoagulant Reversal Drugs Market Share, by Product, 2019 and 2027 (%)

7.3         Prothrombin Complex Concentrates

7.3.1        Overview

7.3.2        Prothrombin Complex Concentrates: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

7.4         Vitamin K

7.4.1        Overview

7.4.2        Vitamin K: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

7.5         Protamine

7.5.1        Overview

7.5.2        Protamine: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

7.6         Tranexamic Acid

7.6.1        Overview

7.6.2        Tranexamic Acid: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

7.7         Idarucizumab

7.7.1        Overview

7.7.2        Idarucizumab: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

7.8         Andexxa

7.8.1        Overview

7.8.2        Andexxa: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

8.           Europe Anticoagulant Reversal Drug Market Analysis and Forecasts to 2027– By Distribution Channel

8.1         Overview

8.2         Anticoagulant Reversal Drugs Market Share, by Distribution Channel, 2019 and 2027 (%)

8.3         Hospital Pharmacies

8.3.1        Overview

8.3.2        Hospital Pharmacies: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

8.4         Retail Pharmacies

8.4.1        Overview

8.4.2        Retail Pharmacies: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

8.5         Others

8.5.1        Overview

8.5.2        Others: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

9.           Anticoagulant Reversal Drug Market Revenue and Forecasts to 2027 – Geographical Analysis

9.1         Europe: Anticoagulant Reversal Drugs Market

9.1.1        Overview

9.1.2        Europe: Anticoagulant Reversal Drugs Market, by Country, 2019 & 2027 (%)

9.1.3        Germany: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)

9.1.3.1          Germany: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)

9.1.3.2          Germany: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)

9.1.3.3          Germany: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

9.1.4        France: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)

9.1.4.1          France: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)

9.1.4.2          France: Anticoagulant Reversal Drugs Market, by Product– Revenue and Forecast to 2027 (USD Million)

9.1.4.3          France: Anticoagulant Reversal Drugs Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)

9.1.5        UK: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)

9.1.5.1          UK: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)

9.1.5.2          UK: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)

9.1.5.3          UK: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

9.1.6        Italy: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.1          Italy: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.2          Italy: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)

9.1.6.3          Italy: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

9.1.7        Spain: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.1          Spain: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.2          Spain: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)

9.1.7.3          Spain: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

9.1.8        Rest of Europe: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.1          Rest of Europe: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.2          Rest of Europe: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)

9.1.8.3          Rest of Europe: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.        Impact Of COVID-19 Pandemic on Europe Anticoagulant Reversal Drug Market

10.1      Europe: Impact Assessment of COVID-19 Pandemic

11.        Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.2.2     Organic Developments Done By Companies

11.3      Inorganic Developments

11.3.1     Overview

11.3.2     Inorganic Developments Done By Companies

Source: The Insight Partners Analysis, Website, Press Releases and Others

12.        COMPANY PROFILES

12.1      Boehringer Ingelheim International GmbH

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Pfizer Inc.

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Octapharma AG

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      AMAG PHARMACEUTICALS, INC.

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Fresenius Kabi AG

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6       Key Developments

12.6      Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      CSL Limited

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Grifols, S.A.

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

13.        Appendix

13.1      About the Insight Partners

13.2      Glossary of Terms

 


 

LIST OF TABLES

Table 1.             Germany: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 2.             Germany: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 3.             France: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 4.             France: Anticoagulant Reversal Drugs Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 5.             UK: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 6.             UK: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 7.             Italy: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 8.             Italy: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 9.             Spain: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 10.          Spain: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 11.          Rest of Europe: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 12.          Rest of Europe: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 13.          Glossary of Terms, Anticoagulant Reversal Drug Market

 


 

LIST OF FIGURES

Figure 1.           Anticoagulant Reversal Drug Market Segmentation

Figure 2.           Europe Anticoagulant Reversal Drug Market Overview

Figure 3.           Prothrombin Complex Concentrates Segment Held Largest Share of Product in Anticoagulant Reversal Drug Market

Figure 4.           Hospital Pharmacies Segment Held Largest Share of Distribution Channel in Anticoagulant Reversal Drug Market

Figure 5.           Germany is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           Anticoagulant Reversal Drug Market - Europe PEST Analysis

Figure 7.           Anticoagulant Reversal Drug Market Impact Analysis of Driver and Restraints

Figure 8.           Europe Anticoagulant Reversal Drug Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 1.           Anticoagulant Reversal Drugs Market Share, by Product, 2019 and 2027 (%)

Figure 2.           Prothrombin Complex Concentrates: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

Figure 3.           Vitamin K: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

Figure 4.           Protamine: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

Figure 5.           Tranexamic Acid: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

Figure 6.           Idarucizumab: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

Figure 7.           Andexxa: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

Figure 8.           Anticoagulant Reversal Drugs Market Share, by Distribution Channel, 2019 and 2027 (%)

Figure 9.           Hospital Pharmacies: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

Figure 10.        Retail Pharmacies: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

Figure 11.        Others: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

Figure 12.        Europe: Anticoagulant Reversal Drugs Market, by Key Country – Revenue (2019) (USD Million)

Figure 13.        Europe: Anticoagulant Reversal Drugs Market, by Country, 2019 & 2027 (%)

Figure 14.        Germany: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 15.        France: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 16.        UK: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 17.        Italy: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 18.        Spain: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 19.        Rest of Europe: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 20.        Impact of COVID-19 Pandemic in European Country Markets

Figure 21.        Growth Strategies Done by the Companies in the Market, (%)

 

 

 

  1. Boehringer Ingelheim International GmbH
  2. Pfizer Inc
  3. Octapharma AG
  4. AMAG PHARMACEUTICALS, INC.
  5. Fresenius Kabi AG
  6. Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)
  7. CSL Limited
  8. Grifols, S.A.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe anticoagulant reversal drug market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe anticoagulant reversal drug market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the anticoagulant reversal drug market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000